MedTrace Logo

Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management

NCT03015363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-08-30

Study results available
· View outcomes & findings →

Summary

The objective of the Cloud DX Pulsewave Health Monitor study is to prospectively calibrate and validate a novel, non-invasive wrist cuff blood pressure device against the gold standard for hemodynamic monitoring (intra-arterial pressure) in voluntarily consented patient participants who are scheduled for an elective cardiac catheterization procedure for clinically valid reasons.

Conditions

Sponsors & Collaborators

  • Horizon Health Network

    collaborator OTHER

  • Dalhousie University

    collaborator OTHER

  • Cloud DX Inc.

    collaborator INDUSTRY

  • New Brunswick Health Research Foundation

    collaborator OTHER

  • Cardiovascular Research New Brunswick

    lead OTHER

Principal Investigators

  • Sohrab Lutchmedial, MD, FRCPC · Cardiovascular Research New Brunswick

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-05-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03015363 on ClinicalTrials.gov